anatabine has been researched along with Innate Inflammatory Response in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abd-Eldayem, AM; Abd-Elhafeez, HH; Abdo, W; Ali, E; Alnasser, SM; Dmerdash, M; Hakamy, A; Haziri, I; Soliman, SA | 1 |
Abdullah, L; Ait-Ghezala, G; Bachmeier, C; Beaulieu-Abdelahad, D; Crawford, F; Mullan, M; Paris, D; Reed, J; Verma, M | 1 |
2 other study(ies) available for anatabine and Innate Inflammatory Response
Article | Year |
---|---|
Anatabine attenuates ovalbumin-induced asthma via oxidative stress and inflammation mitigation and Nrf2/HO-1 signaling upregulation in rats.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Antioxidants; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Heme Oxygenase (Decyclizing); Inflammation; Lung; NF-E2-Related Factor 2; Nicotine; Nitric Oxide Synthase Type II; Ovalbumin; Oxidative Stress; Pyridines; Rats; Up-Regulation | 2022 |
Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.
Topics: Alkaloids; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Cytokines; HEK293 Cells; Humans; Inflammation; Mice; Mice, Inbred C57BL; Phosphorylation; Pyridines; STAT3 Transcription Factor | 2013 |